High Vista Strategies LLC Surface Oncology, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $65,898 - $110,062	-13,932 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $71,889 - $111,177	13,932 New	13,932 $105,000
Q1 2021 May 17, 2021	SELL	$7.25 - $13.82 $73,225 - $139,582	-10,100 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.87 - $10.48 $26,793 - $40,872	-3,900 Reduced 27.86%	10,100 $93,000
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $70,840 - $101,220	14,000 New	14,000 $97,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.